Timing of referral to outpatient palliative care for patients with haematologic malignancies

Br J Haematol. 2022 Sep;198(6):974-982. doi: 10.1111/bjh.18365. Epub 2022 Jul 21.

Abstract

Outpatient palliative-care facilitates timely supportive-care access; however, there is a paucity of studies on the timing of referral in the outpatient setting for patients with haematologic malignancy. We examined the trend in timing of outpatient palliative-care referrals over a 10-year period in patients with haematologic malignancies at our comprehensive cancer centre. We included consecutive patients with a diagnosis of haematologic malignancy who were seen at our outpatient palliative-care clinic between 1 January 2010 and 31 December 2019. We collected data on patient characteristics, symptom burden and supportive-care interventions at outpatient palliative-care consultation. The primary outcome was time from outpatient palliative-care consultation to death or last follow-up. In all, 384 patients were referred by leukaemia (n = 143), lymphoma (n = 213), and stem cell transplant (n = 28) services. The median time from outpatient palliative-care referral to death was 3.4 years (IQR 2.4-5.3) with a significant increase in both the number of referrals per year (p = 0.047) and the timing of referral between 2010 and 2019 (p = 0.001). Patients with haematologic malignancies were referred in a timely fashion to our outpatient palliative-care clinic, with earlier and greater numbers of referrals over time.

Keywords: haematologic malignancy; leukaemia; lymphoma; palliative care; referral; supportive care.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Hematologic Neoplasms* / therapy
  • Humans
  • Neoplasms* / pathology
  • Outpatients
  • Palliative Care
  • Referral and Consultation
  • Retrospective Studies